BioSpace News Archive

Antifungal Drugs Market Demand and Global Competitive Insights 2031

Wilmington, Delaware, United States: The growing threat of fungal infections among a considerable chunk of the global populace is estimated to bring considerable growth prospects for the antifungal drugs market during the forecast period of 2021-2031.

June 17, 2022
·
5 min read
Antibacterial Drugs Market: Increasing Prevalence of Infectious Diseases to Drive the Market

Wilmington, Delaware, United States: Bacterial drugs are the substances that may destroy or constrain the microorganism growth such as bacteria.

June 17, 2022
·
5 min read
Pharmacovigilance Market: Size | Share | Trends | Global Industry Outlook, 2031

Pharmacovigilance is a process refereeing to the detection, collection, prevention, and monitoring of negative effects that may occur because of the use of pharmaceutical products and other drugs.

June 17, 2022
·
8 min read
Oral Care Products Market Segmentation and Analysis Report, 2031

Wilmington, Delaware, United States: The global oral care products market is anticipated to witness moderate growth during the forecast period between 2021 and 2031.

June 17, 2022
·
5 min read
In Vitro Diagnostics (IVD) and Laboratory Developed Tests for Autoimmune Diseases Market | Forecast [2021-2031]

In vitro diagnostics and laboratory developed tests for autoimmune diseases are a key part of the global healthcare sector and are likely to account for a significant share in the same in the coming years due to the rising investment in the healthcare sector from various channels.

June 17, 2022
·
8 min read
BioMidwest

Centene Corporation Announces Increased 2022 Guidance and Value Creation Updates

Centene Corporation will host its June investor day. During the presentation, the Company will discuss its updated 2022 Premium and Service Revenues and Adjusted Diluted Earnings Per Share guidance and provide updates on its Value Creation Plan.

June 17, 2022
·
12 min read
Business

Quotient Limited to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on June 22nd

Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal fourth quarter and full year ended March 31, 2022 will be released before market open on Wednesday, June 22, 2022.

June 17, 2022
·
1 min read
ObsEva Announces European Commission Marketing Authorization for Yselty® (linzagolix), an Oral GnRH Antagonist, for the Treatment of Uterine Fibroids

Yselty® (linzagolix) is the first and only approved GnRH antagonist to provide flexible dosing options with and without hormonal add-back therapy.

June 17, 2022
·
9 min read
Business

Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders and Appoints James T. Parsons to its Board of Directors

Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), today announced the voting results from its Annual General Meeting (AGM) of Shareholders held on Thursday, June 16, 2022.

June 17, 2022
·
6 min read
Drug Development

Addex Terminates Dipraglurant Phase 2b/3 Study in Patients with Dyskinesia Associated with Parkinson’s Disease due to Slow Recruitment Rate

Addex Therapeutics Ltd announced that it has terminated the Phase 2b/3 study evaluating dipraglurant as a potential treatment for dyskinesia associated with Parkinson’s disease due to the slow recruitment of patients.

June 17, 2022
·
4 min read